Base to Base biotech podcast 45: Chronic pain, urology, Affibody molecules and radioligand therapy
Johnson & Johnson prostate cancer drug receives CHMP positive opinion
Breakthru Medicine emerges from stealth to develop cancer drugs
FDA Rare Pediatric Disease designation for mucopolysaccharidosis Type II treatment
KAIST develops AI that automatically designs optimal drug candidates for cancer-targeting mutations
Base to Base biotech podcast 21: Elix drug discovery platform and CytoAgents on CAR-T, CRS and the FDA
Base to Base biotech podcast 18: NETs and AI to tackle antimicrobial resistance
Base to Base biotech podcast 16: Domain Therapeutics, SandboxAQ and LinkGevity
I-Corps Hub West accelerates deeptech commercialisation in western US
Black Sesame Technologies showcases robotics innovation at Asia Tech x Singapore
A new hope for AI development
Could brain-inspired AI help computers see more like humans?